Purpose | AGM Date | Announcement Date | Book Closure Start Date | Book Closure End Date |
---|---|---|---|---|
Board Meeting | - | 06-May-2022 | - | - |
Resignation of CS | ||||
Board Meeting | - | 28-Jan-2022 | - | - |
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Unaudited financial results for the quarter ended 31.12.2021. unaudited financial results for the quarter ended 31.12.2021 (As per BSE Announcement Dated on 14/02/2022) | ||||
Board Meeting | - | 08-Oct-2021 | - | - |
Quarterly Results Un-audited financial results for the quarter ended 30.09.2021 (As Per BSE Announcement dated on 18.10.2021) | ||||
Board Meeting | - | 08-Sep-2021 | - | - |
Outcome of Meeting held on 08.09.2021 | ||||
Board Meeting | - | 02-Aug-2021 | - | - |
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve Unaudited financial results for the quarter ended 30.06.2021 Concord Drugs Ltd has informed BSE regarding Outcome of Board Meeting held on August 13, 2021. (As per BSE Announcement Dated on 13/8/2021) | ||||
Board Meeting | - | 16-Jun-2021 | - | - |
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2021 ,inter alia, to consider and approve Audited results for the period ended 31.03.2021 Audited financial results for the quarter and year ended 31.03.2021 (AS Per BSE Announcement Dated on 28.06.2021) |
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity